4.6 Review

An Original Deal for New Molecule: Reversal of Efflux Pump Activity, A Rational Strategy to Combat Gram-Negative Resistant Bacteria

期刊

CURRENT MEDICINAL CHEMISTRY
卷 18, 期 19, 页码 2969-2980

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986711796150469

关键词

Antibiotic; antibacterial agent; bacterial transporter; chemosensitizer; efflux pump; efflux pump inhibitor; drug transporter; Gram-negative bacteria; genetic regulation cascade; membrane permeability; multidrug resistance

资金

  1. COST Action [BM0701]
  2. Universite de la Mediterranee
  3. Service de Sante des Armees

向作者/读者索取更多资源

The worldwide dissemination of multi-drug resistant (MDR) pathogens has severely reduced the efficacy of our antibiotic arsenal and increased the frequency of therapeutic failure. MDR bacteria over-express efflux pumps and this active mechanism can extrude all classes of antibiotics from the cell. It is necessary to clearly decipher the genetic, structural and functional aspects of this transport system in order to combat this poly-selective mechanism. By understanding how efflux pumps work we may be able to develop a new group of antibacterial agents, collectively termed efflux reversals, including membrane permeabilisers, efflux pump inhibitors and flux-competitive agents, specific blockers, energy poisons, etc. Several chemical families of efflux pump inhibitors have been described and characterized. Among them several inhibitor compounds demonstrate efficient blocking of the efflux pump activity involved in the MDR phenotype as observed in many Gram-negative clinical isolates. This new family of molecules represents the first antibacterial class of compound specifically targeting active transport in the bacterial cell.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据